Helixomer has an ongoing proof-of-concept drug project providing extensive ground-breaking approaches that utilize Helixomer’s RNAO platform. All that has been learned in the project is readily applied to our pipeline of projects through a plug-and-play approach of designing more effective medicines for less cost, higher chances of clinical success, and more rapid design and development.

This pipeline includes oncology, neurodegenerative diseases and cardiology. Our proprietary RNAO platform technology can be applied in various medical applications to address unmet medical and market needs.